We used next generation sequencing (NGS) to investigate the possibility of other (somatic and/or germline) gene variants driving the cancer phenotype and the possibility of BRCA1/2 epigenetic silencing in the context of familial cancer predisposition. Here, BRCA1 is linked to cancer.